Story perspectives

Breakthrough Surgery Offers Hope for Raynaud's Patients

9/3/2025

40 9

Summary

Story summary

Researchers at Yubei District People's Hospital in China have identified a potential cure for Raynaud's, affecting up to 5% of adults.
A minimally invasive surgery, periosteal distraction osteogenesis (PDO), successfully treated gangrene in a 67-year-old patient.
Gene mutations are linked to Raynaud's; the antidepressant mirtazapine may alleviate symptoms, pending further trials.
The study outlines risk factors such as genetics, age, and lifestyle, noting no existing cure.

1 of 1

Story summary

Researchers at Yubei District People's Hospital in China have identified a potential cure for Raynaud's, affecting up to 5% of adults.
A minimally invasive surgery, periosteal distraction osteogenesis (PDO), successfully treated gangrene in a 67-year-old patient.
Gene mutations are linked to Raynaud's; the antidepressant mirtazapine may alleviate symptoms, pending further trials.
The study outlines risk factors such as genetics, age, and lifestyle, noting no existing cure.